Treatment of recalcitrant discoid lupus erythematosus with roflumilast 0.3% cream following suboptimal response to anifrolumab and improvement of hypopigmentation

Document Type

Journal Article

Publication Date

12-1-2024

Journal

JAAD case reports

Volume

54

DOI

10.1016/j.jdcr.2024.09.016

Keywords

anifrolumab; autoimmune; discoid lupus erythematosus; phosphodiesterase type 4 inhibitor; roflumilast 0.3% cream

Department

Dermatology

Share

COinS